By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


VIRxSYS Corporation 

200 Perry Parkway, Suite 1A

Gaithersburg  Maryland  20877  U.S.A.
Phone: 301-987-0480 Fax: 301-987-0489



Start Up

Company News
VIRxSYS Corporation Issued U.S. Patents for its Lentiviral Vector and SMaRT RNA Platforms 11/15/2011 7:51:30 AM
VIRxSYS Corporation Issued Third U.S. Patent This Year for its Spliceosome-Mediated RNA Trans-Splicing (SMaRT(TM)) Program; Breakthrough RNA Therapeutic Platform 9/22/2011 8:51:47 AM
Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS Corporation' HIV Vaccine VRX1273 7/18/2011 8:33:15 AM
Researchers to Present Results From Two VIRxSYS Corporation HIV Studies at the 6th International AIDS Society Meeting 6/28/2011 9:26:19 AM
VIRxSYS Corporation Presents New Therapeutic Vaccine Data at HIV DART 2010 12/9/2010 8:26:30 AM
VIRxSYS Corporation Demonstrates "Functional Cure" and Survival Benefit for the Simian Model of HIV in Preclinical Vaccine Study 10/1/2010 8:26:20 AM
VIRxSYS Corporation Presents Results from Multiple Studies at the 13th ASGCT Annual Meeting 5/23/2010 8:57:07 PM
Fight HIV With HIV: 'Safe' Virus Proposed As Vaccine By VIRxSYS Corporation 2/19/2010 7:50:42 AM
VIRxSYS Corporation Awarded Maryland Stem Cell Grant 6/15/2009 11:49:04 AM
VIRxSYS Corporation Publishes New Study on RNA Therapy 4/6/2009 9:46:16 AM